Abbott, CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes. The initial focus of the partnership will be in European countries. The new integrated AID system is being designed to connect…
eTurboNews les articles sont réservés aux abonnés. L'abonnement est GRATUIT.
Connexion Cliquez ici pour vous abonner GRATUITEMENT
Connexion Cliquez ici pour vous abonner GRATUITEMENT
QUE RETENIR DE CET ARTICLE :
- The initial focus of the partnership will be in European countries.
- Abbott, CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes.
- The new integrated AID system is being designed to connect….
